The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities
Open accessAbstract
Tumor hypoxia is a well-established biological phenomenon that affects the curability of solid tumors, regardless of treatment modality. Especially for head and neck cancer patients, tumor hypoxia is linked to poor patient outcomes. Given the biological problems associated with tumor hypoxia, the goal for clinicians has been to identify moderately to severely hypoxic tumors for differential treatment strategies. The “gold standard” for detecting and characterizing of tumor hypoxia are the invasive polarographic electrodes. Several less invasive hypoxia assessment techniques have also shown promise for hypoxia assessment. The widespread incorporation of hypoxia information in clinical tumor assessment is severely impeded by several factors, including regulatory hurdles and unclear correlation with potential treatment decisions. There is now an acute need for approved diagnostic technologies for determining the hypoxia status of cancer lesions, as it would enable clinical development of personalized, hypoxia-based therapies, which will ultimately improve outcomes. A number of different techniques for assessing tumor hypoxia have evolved to replace polarographic pO2 measurements for assessing tumor hypoxia. Several of these modalities, either individually or in combination with other imaging techniques, provide functional and physiological information of tumor hypoxia that can significantly improve the course of treatment. The assessment of tumor hypoxia will be valuable to radiation oncologists, surgeons, and biotechnology and pharmaceutical companies who are engaged in developing hypoxia-based therapies or treatment strategies. Antioxid. Redox Signal. 21, 1516–1554. I. Introduction II. The Clinical Importance of Tumor Hypoxia A. Pathophysiology of hypoxia B. Hypoxia's negative impact on the effectiveness of curative treatment 1. Hypoxic tumors accumulate and propagate cancer stem cells 2. Hypoxia reduces the effectiveness of radiotherapy 3. Hypoxia increases metastasis risk and reduces the effectiveness of surgery 4. Hypoxic tumors are resistant to the effects of chemotherapy and chemoradiation C. Hypoxia is prognostic for poor patient outcomes III. Diagnosis of Tumor Hypoxia A. Direct methods 1. Oxygen electrode—direct pO2 measurement most used in cancer research 2. Phosphorescence quenching—alternative direct pO2 measurement 3. Electron paramagnetic resonance 4. 19F-magnetic resonance spectroscopy 5. Overhauser-enhanced MRI B. Endogenous markers of hypoxia 1. Hypoxia-inducible factor-1α 2. Carbonic anhydrase IX 3. Glucose transporter 1 4. Osteopontin 5. A combined IHC panel of protein markers for hypoxia 6. Comet assay C. Physiologic methods 1. Near-infrared spectroscopy/tomography—widely used for pulse oximetry 2. Photoacoustic tomography 3. Contrast-enhanced color duplex sonography 4. MRI-based measurements 5. Blood oxygen level-dependent MRI 6. Pimonidazole 7. EF5 (pentafluorinated etanidazole) 8. Hypoxia PET imaging—physiologic hypoxia measurement providing tomographic information a. 18F-fluoromisonidazole b. 18F-fluoroazomycinarabinofuranoside c. 18F-EF5 (pentafluorinated etanidazole) d. 18F-flortanidazole e. Copper (II) (diacetyl-bis (N4-methylthiosemicarbazone)) f. 18F-FDG imaging of hypoxia IV. Modifying Hypoxia to Improve Therapeutic Outcomes A. Use of hypoxia information in radiation therapy planning B. Use of hypoxia assessment for selection of patients responsive to nimorazole C. Use of hypoxia assessment for selection of patients responsive to tirapazamine D. Use of hypoxia assessment for selection of patients responsive to oxygen delivery therapies V. Concluding Remarks
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 3×
“It is constantly expressed and degraded via oxygen-dependent oxidation; therefore, its degradation is slowed at low oxygen pressure (103) with elevated protein levels found in many hypoxic tumors (245).”
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Exploiting tumour hypoxia in cancer treatment
Brown, J. M., & Wilson, W. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1367 · Cited by 2,828
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 2×
“This survival mechanism is common among hypoxic tumors, resulting in a twofold increase in glucose uptake (determined in vitro) (29), elevated tissue acidity (44), and an evolutionary selection for a progressively more malignant phenotype (102, 122).”
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1999) · PubMed · Cited by 2,204
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, P., & Jain, R. K. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3455 · Cited by 1,675
(2000) · PubMed · Cited by 1,445
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Hypoxia-inducible expression of tumor-associated carbonic anhydrases.
Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K., Pastorek, J., Sibtain, A., Wilson, G. D., Turley, H., Talks, K., Maxwell, P. H., et al. (2000) · PubMed · Cited by 1,286
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
(1996) · PubMed · Cited by 1,188
Hudson, C. C., Liu, M., Chiang, G. G., Otterness, D. M., Loomis, D. C., Kaper, F., Giaccia, A. J., & Abraham, R. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7004-7014.2002 · Cited by 1,186
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions
Lee, J.-W., Bae, S.-H., Jeong, J.-W., Kim, S.-H., & Kim, K.-W. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.1 · Cited by 1,117
Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors
Moeller, B. J., Cao, Y., Li, C. Y., & Dewhirst, M. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00115-1 · Cited by 996
Oxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.038 · Cited by 953
Vaupel, P. W., Schlenger, K., Knoop, C., & Höckel, M. (1991) · PubMed · Cited by 952
Nordsmark, M., Overgaard, M., & Overgaard, J. (1996) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(96)91811-3 · Cited by 942
The Role of Hypoxia-Induced Factors in Tumor Progression
Vaupel, P. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-10 · Cited by 827
Mazzone, M., Dettori, D., Leite de Oliveira, R., Loges, S., Schmidt, T., Jonckx, B., Tian, Y.-M., Lanahan, A. A., Pollard, P., Ruiz de Almodovar, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.020 · Cited by 812
Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix
Höckel, M., Knoop, C., Schlenger, K., Vorndran, B., Bauβnann, E., Mitze, M., Knapstein, P. G., & Vaupel, P. (1993) · Radiotherapy and Oncology · doi:10.1016/0167-8140(93)90025-4 · Cited by 809
Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., & Broder, G. J. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90002-8 · Cited by 798
Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response
Vaupel, P., & Harrison, L. (2004) · The Oncologist · doi:10.1634/theoncologist.9-90005-4 · Cited by 761
Detection and Characterization of Tumor Hypoxia Using pO 2 Histography
Vaupel, P., Höckel, M., & Mayer, A. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1628 · Cited by 728
Hypoxia and hypoxia-inducible factors: master regulators of metastasis
Lu, X., & Kang, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1360 · Cited by 723
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695 · cited 1×
“Selective targeting of critical proteins, including VEGF, VEGF receptor 2 (VEGFR2) (290), regulator of G-protein signaling 5 (RGS5) (115), angiopoietin-2 (ANG2) (35), placenta growth factor (PlGF) (234), and prolyl hydroxylase domain protein 2 (PHD2) FIG.”
Overgaard, J., Hansen, H. S., Specht, L., Overgaard, M., Grau, C., Andersen, E., Bentzen, J., Bastholt, L., Hansen, O., Johansen, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14361-9 · Cited by 685
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Chiche, J., Brahimi‐Horn, M. C., & Pouysségur, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00994.x · Cited by 667
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Conley, S. J., Gheordunescu, E., Kakarala, P., Newman, B., Korkaya, H., Heath, A. N., Clouthier, S. G., & Wicha, M. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018866109 · Cited by 663
Pancreatic tumors show high levels of hypoxia
Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., Brown, J. M., Bastidas, A. J., & Vierra, M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00803-8 · Cited by 650
Brown, J. M. (1999) · PubMed · Cited by 633
Tatum, J. L. (2006) · International Journal of Radiation Biology · doi:10.1080/09553000601002324 · Cited by 620
Progress of near-infrared spectroscopy and topography for brain and muscle clinical applications
Ferrari, M. (2007) · Journal of Biomedical Optics · doi:10.1117/1.2804899 · Cited by 600
Overgaard, J., Sand Hansen, H., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 573
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 564
Teicher, B. A. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00689633 · Cited by 563
Treatment Resistance of Solid Tumors
Vaupel, P., Thews, O., & Hoeckel, M. (2001) · Medical Oncology · doi:10.1385/mo:18:4:243 · Cited by 558
Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome
Brizel, D. M., Dodge, R. K., Clough, R. W., & Dewhirst, M. W. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00102-4 · Cited by 548
Rischin, D., Hicks, R. J., Fisher, R., Binns, D., Corry, J., Porceddu, S., & Peters, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2878 · Cited by 541
Imaging of phosphorescence: a novel method for measuring oxygen distribution in perfused tissue
Rumsey, W., Vanderkooi, J., & Wilson, D. (1988) · Science · doi:10.1126/science.241.4873.1649 · Cited by 534
Semenza, G. L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.006 · Cited by 483
Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 482
Glucose transporters: expression, regulation and cancer
MEDINA, R. A., & OWEN, G. I. (2002) · Biological Research · doi:10.4067/s0716-97602002000100004 · Cited by 472
Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease
Boushel, R., Langberg, H., Olesen, J., Gonzales‐Alonzo, J., Bülow, J., & Kjær, M. (2001) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1034/j.1600-0838.2001.110404.x · Cited by 469
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
Koh, W.-J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., & Griffin, T. W. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91001-4 · Cited by 463
Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.03.004 · Cited by 456
Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging
Choyke, P. L., Dwyer, A. J., & Knopp, M. V. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10304 · Cited by 439
Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., & Harris, A. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3660 · Cited by 432
Chao, K. S. C., Bosch, W. R., Mutic, S., Lewis, J. S., Dehdashti, F., Mintun, M. A., Dempsey, J. F., Perez, C. A., Purdy, J. A., & Welch, M. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01433-4 · Cited by 429
Hypoxia-driven selection of the metastatic phenotype
Sullivan, R., & Graham, C. H. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9062-2 · Cited by 410
Eschmann, S. M., Paulsen, F., Reimold, M., Dittmann, H., Welz, S., Reischl, G., Machulla, H.-J., & Bares, R. (2005) · PubMed · Cited by 400
Kunkel, M., Reichert, T. E., Benz, P., Lehr, H., Jeong, J., Wieand, S., Bartenstein, P., Wagner, W., & Whiteside, T. L. (2003) · Cancer · doi:10.1002/cncr.11159 · Cited by 390
Hypoxia and Glucose Metabolism in Malignant Tumors
Rajendran, J. G., Mankoff, D. A., O’Sullivan, F., Peterson, L. M., Schwartz, D. L., Conrad, E. U., Spence, A. M., Muzi, M., Farwell, D. G., & Krohn, K. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0688-3 · Cited by 390
Rischin, D., Peters, L. J., O'Sullivan, B., Giralt, J., Fisher, R., Yuen, K., Trotti, A., Bernier, J., Bourhis, J., Ringash, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4449 · Cited by 380
Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes
Harrison, L. B., Chadha, M., Hill, R. J., Hu, K., & Shasha, D. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-492 · Cited by 376
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM
Dehdashti, F., Mintun, M. A., Lewis, J. S., Bradley, J., Govindan, R., Laforest, R., Welch, M. J., & Siegel, B. A. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1130-4 · Cited by 368
Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders, J. H. A. M., Wijffels, K. I. E. M., Marres, H. A. M., Ljungkvist, A. S. E., Pop, L. A. M., van den Hoogen, F. J. A., de Wilde, P. C. M., Bussink, J., Raleigh, J. A., & van der Kogel, A. J. (2002) · PubMed · Cited by 357
Rajendran, J. G., Schwartz, D. L., O'Sullivan, J., Peterson, L. M., Ng, P., Scharnhorst, J., Grierson, J. R., & Krohn, K. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1773 · Cited by 354
Li, M.-L., Oh, J.-T., Xie, X., Ku, G., Wang, W., Li, C., Lungu, G., Stoica, G., & Wang, L. V. (2008) · Proceedings of the IEEE · doi:10.1109/jproc.2007.913515 · Cited by 352
The hypoxic tumour microenvironment and metastatic progression
Subarsky, P., & Hill, R. P. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022939318102 · Cited by 327
Dehdashti, F., Grigsby, P. W., Mintun, M. A., Lewis, J. S., Siegel, B. A., & Welch, M. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04477-2 · Cited by 326
Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
Piert, M., Machulla, H. ‐., Picchio, M., Reischl, G., Ziegler, S. I., Kumar, P., Wester, H.-J., Beck, R., McEwan, A. J. B., Wiebe, L. I., et al. (2005) · PubMed · Cited by 319
Mortensen, L. S., Johansen, J., Kallehauge, J., Primdahl, H., Busk, M., Lassen, P., Alsner, J., Sørensen, B. S., Toustrup, K., Jakobsen, S., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.09.015 · Cited by 308
A marker for hypoxic cells in tumours with potential clinical applicability
Chapman, J. D., Franko, A. J., & Sharplin, J. (1981) · British Journal of Cancer · doi:10.1038/bjc.1981.79 · Cited by 306
Raleigh, J. A., Chou, S.-C., Arteel, G. E., & Horsman, M. R. (1999) · Radiation Research · doi:10.2307/3580034 · Cited by 304
Stone, H. B., Brown, J. M., Phillips, T. L., & Sutherland, R. M. (1993) · Radiation Research · doi:10.2307/3578556 · Cited by 303
Hypoxia Dose Painting by Numbers: A Planning Study
Thorwarth, D., Eschmann, S.-M., Paulsen, F., & Alber, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.061 · Cited by 301
(2002) · PubMed · Cited by 296
Arteel, G., Thurman, R., Yates, J., & Raleigh, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.429 · Cited by 295
Le, Q.-T., Chen, E., Salim, A., Cao, H., Kong, C. S., Whyte, R., Donington, J., Cannon, W., Wakelee, H., Tibshirani, R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2049 · Cited by 290
Oxyphor R2 and G2: phosphors for measuring oxygen by oxygen-dependent quenching of phosphorescence
Dunphy, I., Vinogradov, S. A., & Wilson, D. F. (2002) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00384-6 · Cited by 288
The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis
Hamada, K., Sasaki, T., Koni, P. A., Natsui, M., Kishimoto, H., Sasaki, J., Yajima, N., Horie, Y., Hasegawa, G., Naito, M., et al. (2005) · Genes & Development · doi:10.1101/gad.1308805 · Cited by 287
Dings, R. P. M., Loren, M., Heun, H., McNiel, E., Griffioen, A. W., Mayo, K. H., & Griffin, R. J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2441 · Cited by 286
HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers
Baba, Y., Nosho, K., Shima, K., Irahara, N., Chan, A. T., Meyerhardt, J. A., Chung, D. C., Giovannucci, E. L., Fuchs, C. S., & Ogino, S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090972 · Cited by 285
von Pawel, J., von Roemeling, R., Gatzemeier, U., Boyer, M., Elisson, L. O., Clark, P., Talbot, D., Rey, A., Butler, T. W., Hirsh, V., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1351 · Cited by 285
Vergis, R., Corbishley, C. M., Norman, A. R., Bartlett, J., Jhavar, S., Borre, M., Heeboll, S., Horwich, A., Huddart, R., Khoo, V., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70076-7 · Cited by 282
Nordsmark, M., & Overgaard, J. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00223-1 · Cited by 281
Zips, D., Zöphel, K., Abolmaali, N., Perrin, R., Abramyuk, A., Haase, R., Appold, S., Steinbach, J., Kotzerke, J., & Baumann, M. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.08.019 · Cited by 280
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Xia, Y., Choi, H.-K., & Lee, K. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.01.033 · Cited by 278
Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274
Chang, Q., Jurisica, I., Do, T., & Hedley, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4049 · Cited by 272
Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
Stadler, P., Becker, A., Jürgen Feldmann, H., Hänsgen, G., Dunst, J., Würschmidt, F., & Molls, M. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00115-7 · Cited by 266
Janssens, G. O., Rademakers, S. E., Terhaard, C. H., Doornaert, P. A., Bijl, H. P., van den Ende, P., Chin, A., Marres, H. A., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 256
Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penniment, M., Corry, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.072 · Cited by 253
Two New “Protected” Oxyphors for Biological Oximetry: Properties and Application in Tumor Imaging
Esipova, T. V., Karagodov, A., Miller, J., Wilson, D. F., Busch, T. M., & Vinogradov, S. A. (2011) · Analytical Chemistry · doi:10.1021/ac2022234 · Cited by 247
Lee, N. Y., Mechalakos, J. G., Nehmeh, S., Lin, Z., Squire, O. D., Cai, S., Chan, K., Zanzonico, P. B., Greco, C., Ling, C. C., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.039 · Cited by 235
Grosu, A.-L., Souvatzoglou, M., Röper, B., Dobritz, M., Wiedenmann, N., Jacob, V., Wester, H.-J., Reischl, G., Machulla, H.-J., Schwaiger, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.05.079 · Cited by 229
The chemoradiation paradigm in head and neck cancer
Seiwert, T. Y., Salama, J. K., & Vokes, E. E. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0750 · Cited by 227
Teicher, B. A., Holden, S. A., Al-Achi, A., & Herman, T. S. (1990) · PubMed · Cited by 225
Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications
Gallez, B., Baudelet, C., & Jordan, B. F. (2004) · NMR in Biomedicine · doi:10.1002/nbm.900 · Cited by 222
Airley, R. E., Loncaster, J., Raleigh, J. A., Harris, A. L., Davidson, S. E., Hunter, R. D., West, C. M. L., & Stratford, I. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.10904 · Cited by 221
Toustrup, K., Sørensen, B. S., Lassen, P., Wiuf, C., Alsner, J., & Overgaard, J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.09.010 · Cited by 221
Maione, F., Molla, F., Meda, C., Latini, R., Zentilin, L., Giacca, M., Seano, G., Serini, G., Bussolino, F., & Giraudo, E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36308 · Cited by 219
Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors.
Overgaard, J. (1994) · PubMed · Cited by 218
Baudelet, C., & Gallez, B. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10318 · Cited by 218
Hoskin, P. J., Sibtain, A., Daley, F. M., & Wilson, G. D. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601260 · Cited by 217
Bruehlmeier, M., Roelcke, U., Schubiger, P. A., & Ametamey, S. M. (2004) · PubMed · Cited by 216
Comparative Measurements of Hypoxia in Human Brain Tumors Using Needle Electrodes and EF5 Binding
Evans, S. M., Judy, K. D., Dunphy, I., Jenkins, W. T., Nelson, P. T., Collins, R., Wileyto, E. P., Jenkins, K., Hahn, S. M., Stevens, C. W., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2424 · Cited by 216
Kong, C. S., Narasimhan, B., Cao, H., Kwok, S., Erickson, J. P., Koong, A., Pourmand, N., & Le, Q.-T. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.015 · Cited by 212
Dehdashti, F., Grigsby, P. W., Lewis, J. S., Laforest, R., Siegel, B. A., & Welch, M. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048520 · Cited by 212
Cooper, R. A., Carrington, B. M., Loncaster, J. A., Todd, S. M., Davidson, S. E., Logue, J. P., Luthra, A. D., Jones, A. P., Stratford, I., Hunter, R. D., et al. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00259-0 · Cited by 210
Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
Nehmeh, S. A., Lee, N. Y., Schröder, H., Squire, O., Zanzonico, P. B., Erdi, Y. E., Greco, C., Mageras, G., Pham, H. S., Larson, S. M., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.036 · Cited by 210
Rademakers, S. E., Lok, J., van der Kogel, A. J., Bussink, J., & Kaanders, J. H. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-167 · Cited by 210
Involvement of Hypoxia-Inducible Factor 1 in Human Cancer.
SEMENZA, G. L. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.79 · Cited by 208
Dirix, P., Vandecaveye, V., De Keyzer, F., Stroobants, S., Hermans, R., & Nuyts, S. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.062638 · Cited by 207
Characterization of Radiolabeled Fluoromisonidazole as a Probe for Hypoxic Cells
Rasey, J. S., Grunbaum, Z., Magee, S., Nelson, N. J., Olive, P. L., Durand, R. E., & Krohn, K. A. (1987) · Radiation Research · doi:10.2307/3576986 · Cited by 207
Gross, M. W., Karbach, U., Groebe, K., Franko, A. J., & Mueller‐Klieser, W. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610422 · Cited by 206
Rischin, D., Peters, L., Hicks, R., Hughes, P., Fisher, R., Hart, R., Sexton, M., D’Costa, I., & von Roemeling, R. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.535 · Cited by 201
Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
Helczynska, K., Kronblad, Å., Jögi, A., Nilsson, E., Beckman, S., Landberg, G., & Påhlman, S. (2003) · PubMed · Cited by 200
Molecular responses to hypoxia in tumor cells.
Kunz, M., & Ibrahim, S. M. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-23 · Cited by 196
Graham, C. H., Forsdike, J., Fitzgerald, C. J., & Macdonald-Goodfellow, S. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990209)80:4<617::aid-ijc22>3.0.co;2-c · Cited by 192
Hendrickson, K., Phillips, M., Smith, W., Peterson, L., Krohn, K., & Rajendran, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.07.029 · Cited by 190
Detection of hypoxia in human squamous cell carcinoma by EF5 binding.
Evans, S. M., Hahn, S. M., Pook, D. R., Jenkins, W. T., Chalian, A. A., Zhang, P. J., Stevens, C., Weber, R. S., Weinstein, G. S., Benjamin, I., et al. (2000) · PubMed · Cited by 190
The OxyLite: a fibre-optic oxygen sensor.
Griffiths, J. R., & Robinson, S. P. (1999) · The British Journal of Radiology · doi:10.1259/bjr.72.859.10624317 · Cited by 186
Lewis, J. S., Sharp, T. L., Laforest, R. A., Fujibayashi, Y., & Welch, M. J. (2001) · PubMed · Cited by 186
ARCON: experience in 215 patients with advanced head-and-neck cancer
Kaanders, J. H. A. M., Pop, L. A. M., Marres, H. A. M., Bruaset, I., van den Hoogen, F. J. A., Merkx, M. A. W., & van der Kogel, A. J. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02678-5 · Cited by 184
İlie, M., Mazure, N. M., Hofman, V, Ammadi, R. E., Ortholan, C., Bonnetaud, C., Havet, K., Venissac, N., Mograbi, B., Mouroux, J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605690 · Cited by 184
BOLD MRI of human tumor oxygenation during carbogen breathing
Taylor, N. J., Baddeley, H., Goodchild, K. A., Powell, M. E. B., Thoumine, M., Culver, L. A., Stirling, J. J., Saunders, M. I., Hoskin, P. J., Phillips, H., et al. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1166 · Cited by 183
Hoskin, P. J., Carnell, D. M., Taylor, N. J., Smith, R. E., Stirling, J. J., Daley, F. M., Saunders, M. I., Bentzen, S. M., Collins, D. J., d’Arcy, J. A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.018 · Cited by 182
18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer
Komar, G., Seppänen, M., Eskola, O., Lindholm, P., Grönroos, T. J., Forsback, S., Sipilä, H., Evans, S. M., Solin, O., & Minn, H. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.053785 · Cited by 181
Lee, D.-J., Cosmatos, D., Marcial, V. A., Fu, K. K., Rotman, M., Cooper, J. S., Ortiz, H. G., Beitler, J. J., Abrams, R. A., Curran, W. J., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00150-w · Cited by 179
Koch, C., Evans, S., & Lord, E. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.426 · Cited by 178
Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study
Souvatzoglou, M., Grosu, A. L., Röper, B., Krause, B. J., Beck, R., Reischl, G., Picchio, M., Machulla, H.-J., Wester, H.-J., & Piert, M. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0424-3 · Cited by 172
Hypoxic regions exist in human prostate carcinoma
Movsas, B., Chapman, J. D., Horwitz, E. M., Pinover, W. H., Greenberg, R. E., Hanlon, A. L., Iyer, R., & Hanks, G. E. (1999) · Urology · doi:10.1016/s0090-4295(98)00500-7 · Cited by 171
Influence of Unrecognized Molecular Heterogeneity on Randomized Clinical Trials
Betensky, R. A., Louis, D. N., & Gregory Cairncross, J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.140 · Cited by 167
Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix
Loncaster, J. A., Carrington, B. M., Sykes, J. R., Jones, A. P., Todd, S. M., Cooper, R., Buckley, D. L., Davidson, S. E., Logue, J. P., Hunter, R. D., et al. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02972-3 · Cited by 166
Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer
Kim, S. J., Rabbani, Z. N., Dewhirst, M. W., Vujaskovic, Z., Vollmer, R. T., Schreiber, E.-G., Oosterwijk, E., & Kelley, M. J. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.036 · Cited by 165
Dietz, D. W., Dehdashti, F., Grigsby, P. W., Malyapa, R. S., Myerson, R. J., Picus, J., Ritter, J., Lewis, J. S., Welch, M. J., & Siegel, B. A. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9420-3 · Cited by 165
Collingridge, D. R., Piepmeier, J. M., Rockwell, S., & Knisely, J. P. S. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00121-8 · Cited by 164
Postema, E. J., McEwan, A. J. B., Riauka, T. A., Kumar, P., Richmond, D. A., Abrams, D. N., & Wiebe, L. I. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1154-5 · Cited by 164
Thorwarth, D., Eschmann, S.-M., Holzner, F., Paulsen, F., & Alber, M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.033 · Cited by 160
Conventional cancer therapy: promise broken or promise delayed?
Tannock, I. F. (1998) · The Lancet · doi:10.1016/s0140-6736(98)90327-0 · Cited by 160
A Factor of Importance in the Radio Sensitivity of Tumours
Mottram, J. C. (1936) · British Journal of Radiology · doi:10.1259/0007-1285-9-105-606 · Cited by 152
Hypoxic stress proteins: Survival of the fittest
Giaccia, A. J. (1996) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(96)80035-x · Cited by 151
Hypoxia-Induced increase in FDG uptake in MCF7 cells.
Burgman, P., O’Donoghue, J. A., Humm, J. L., et al. (2001) · PubMed · Cited by 150
Adams, G. E., Ahmed, I., SHELDON, P. W., & Stratford, I. J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.91 · Cited by 143
Okamoto, S., Shiga, T., Yasuda, K., Ito, Y. M., Magota, K., Kasai, K., Kuge, Y., Shirato, H., & Tamaki, N. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.109330 · Cited by 143
Nordsmark, M., & Overgaard, J. (2004) · Acta Oncologica · doi:10.1080/02841860410026189 · Cited by 141
Preclinical evaluation and validation of [ 18 F]HX4, a promising hypoxia marker for PET imaging
Dubois, L. J., Lieuwes, N. G., Janssen, M. H. M., Peeters, W. J. M., Windhorst, A. D., Walsh, J. C., Kolb, H. C., Öllers, M., Bussink, J., van Dongen, G. A. M. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102526108 · Cited by 136
Self-citationNoninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5
Ziemer, L. S., Evans, S. M., Kachur, A. V., Shuman, A. G., Cardi, C. A., Jenkins, W. T., Karp, J. S., Alavi, A., Dolbier, W. R., & Koch, C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1037-5 · Cited by 136
Chae, S.-S., Kamoun, W. S., Farrar, C. T., Kirkpatrick, N. D., Niemeyer, E., de Graaf, A. M. A., Sorensen, A. G., Munn, L. L., Jain, R. K., & Fukumura, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3073 · Cited by 135
Stereotactic Ablative Radiotherapy Should Be Combined With a Hypoxic Cell Radiosensitizer
Brown, J. M., Diehn, M., & Loo, B. W. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.04.070 · Cited by 133
Elas, M., Ahn, K., Parasca, A. D., Barth, E. D., Lee, D., Haney, C. R., & Halpern, H. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0446 · Cited by 132
Jin, F., Brockmeier, U., Otterbach, F., & Metzen, E. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0498 · Cited by 130
Zimny, M., Gagel, B., DiMartino, E., Hamacher, K., Coenen, H. H., Westhofen, M., Eble, M. J., Buell, U., & Reinartz, P. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0175-6 · Cited by 130
Endogenous Markers of Tumor Hypoxia
Vordermark, D., & Brown, J. M. (2003) · Strahlentherapie und Onkologie · doi:10.1007/s00066-003-1150-9 · Cited by 128
Cerniglia, G. J., Pore, N., Tsai, J. H., Schultz, S. M., Mick, R., Choe, R., Xing, X., Durduran, T., Yodh, A. G., Evans, S. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006539 · Cited by 128
Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice
Yasui, H., Matsumoto, S., Devasahayam, N., Munasinghe, J., Choudhuri, R., Saito, K., Subramanian, S., Mitchell, J. B., & Krishna, M. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1350 · Cited by 127
Potential use of the comet assay in the clinical management of cancer
McKenna, D. J., McKeown, S. R., & McKelvey‐Martin, V. J. (2008) · Mutagenesis · doi:10.1093/mutage/gem054 · Cited by 126
Le, Q., Kong, C. S., Lavori, P. W., O'Byrne, K. J., Erler, J. T., Huang, X., Chen, Y., Cao, H., Tibshirani, R. J., Denko, N., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.071 · Cited by 121
Eschmann, S. M., Paulsen, F., Bedeshem, C., Machulla, H., Hehr, T., Bamberg, M., & Bares, R. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.014 · Cited by 118
PET imaging of hypoxia using [18F]HX4: a phase I trial
van Loon, J., Janssen, M. H. M., Öllers, M., Aerts, H. J. W. L., Dubois, L. J., Hochstenbag, M. M. H., Dingemans, A. C., Lalisang, R. I., Brans, B. T., Windhorst, A. D., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1437-x · Cited by 118
Self-citationBentzen, L., Keiding, S., Nordsmark, M., Falborg, L., Hansen, S. B., Keller, J. O., Nielsen, O. S., & Overgaard, J. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(03)00081-1 · Cited by 117
Chen, Y., Wei, Y., Chen, H., Fong, Y., Hsu, C., Tsai, C., Hsu, H., Liu, S., & Tang, C. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21835 · Cited by 117
Intratumoral oxygen pressure in malignant brain tumor
Kayama, T., Yoshimoto, T., Fujimoto, S., & Sakurai, Y. (1991) · Journal of neurosurgery · doi:10.3171/jns.1991.74.1.0055 · Cited by 116
Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice
Matsumoto, S., Hyodo, F., Subramanian, S., Devasahayam, N., Munasinghe, J., Hyodo, E., Gadisetti, C., Cook, J. A., Mitchell, J. B., & Krishna, M. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34928 · Cited by 113
Mack, P. C., Redman, M. W., Chansky, K., Williamson, S. K., Farneth, N. C., Lara, P. N., Franklin, W. A., Le, Q., Crowley, J. J., & Gandara, D. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0662 · Cited by 112
Gagel, B., Reinartz, P., DiMartino, E., Zimny, M., Pinkawa, M., Maneschi, P., Stanzel, S. F., Hamacher, K., Coenen, H. H., Westhofen, M., et al. (2004) · Strahlentherapie und Onkologie · doi:10.1007/s00066-004-1229-y · Cited by 110
Targeting hypoxic tumour cells to overcome metastasis
Bennewith, K. L., & Dedhar, S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-504 · Cited by 109
Frederiksen, L. J., Siemens, D. R., Heaton, J. P. W., Maxwell, L., ADAMS, M. A., & Graham, C. H. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000081126.71235.e0 · Cited by 107
Nordsmark, M., Loncaster, J. A., Aquino‐Parsons, C., Chou, S.-C., Gebski, V., West, C., Lindegaard, J. C., Havsteen, H., Davidson, S. E., Hunter, R. D., et al. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.010 · Cited by 105
Chopra, S., Foltz, W. D., Milosevic, M., Toi, A., Bristow, R. G., Ménard, C. M., & Haider, M. A. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000903043059 · Cited by 103
Dose prescription and treatment planning based on FMISO-PET hypoxia
Toma-Daşu, I., Uhrdin, J., Antonovic, L., Daşu, A., Nuyts, S., Dirix, P. R., Haustermans, K. M., & Brahme, A. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.599815 · Cited by 103
Tumour hypoxia, hypoxia signaling pathways and hypoxia inducible factor expression in human cancer.
Giatromanolaki, A. N., & Harris, A. L. (2001) · PubMed · Cited by 100
Vaupel, P. W., Mayer, A., Briest, S., & Höckel, M. (2003) · PubMed · Cited by 100
Hoogsteen, I. J., Marres, H. A. M., Bussink, J., van der Kogel, A. J., & Kaanders, J. H. A. M. (2007) · Head & Neck · doi:10.1002/hed.20543 · Cited by 100
Pogue, B. W., O’Hara, J. A., Wilmot, C. M., Paulsen, K. D., & Swartz, H. M. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0015:eoodir]2.0.co;2 · Cited by 99
Tissue oxygen distribution in head and neck cancer patients
Adam, M., Gabalski, E. C., Bloch, D. A., Oehlert, J. W., Brown, J. M., Elsaid, A. A., Pinto, H. A., & Terris, D. J. (1999) · Head & Neck · doi:10.1002/(sici)1097-0347(199903)21:2<146::aid-hed8>3.0.co;2-u · Cited by 97
Popple, R. A., Ove, R., & Shen, S. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03007-9 · Cited by 97
Rudat, V., Stadler, P. F., Becker, A., Vanselow, B., Dietz, A., Wannenmacher, M., Molls, M., Dunst, J., & Feldmann, H. J. (2001) · Strahlentherapie und Onkologie · doi:10.1007/pl00002427 · Cited by 95
Jonathan, R. A., Wijffels, K. I. E. M., Peeters, W. J. M., de Wilde, P. C. M., Marres, H. A. M., Merkx, M. A. W., Oosterwijk, E., van der Kogel, A. J., & Kaanders, J. H. A. M. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.04.008 · Cited by 95
Matsumoto, S., Yasui, H., Batra, S., Kinoshita, Y., Bernardo, M., Munasinghe, J., Utsumi, H., Choudhuri, R., Devasahayam, N., Subramanian, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908447106 · Cited by 93
Six Degrees of Separation: The Oxygen Effect in the Development of Radiosensitizers
Oronsky, B. T., Knox, S. J., & Scicinski, J. J. (2011) · Translational Oncology · doi:10.1593/tlo.11166 · Cited by 93
Tumor Volume and Tumor Hypoxia in Head and Neck Cancers
Dunst, J., Stadler, P. F., Becker, A., Lautenschläger, C., Pelz, T., Hänsgen, G., Molls, M., & Kuhnt, T. (2003) · Strahlentherapie und Onkologie · doi:10.1007/s00066-003-1066-4 · Cited by 92
Osteosarcomas of the skull. Clinical remarks on 19 cases
Salvati, M., Ciappetta, P., & Raco, A. (1993) · Cancer · doi:10.1002/1097-0142(19930401)71:7<2319::aid-cncr2820710724>3.0.co;2-c · Cited by 91
Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Graves, E. E., Vilalta, M., Cecić, I., Erler, J. T., Tran, P. T., Felsher, D. W., Sayles, L. C., Sweet-Cordero, A., Le, Q., & Giaccia, A. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1206 · Cited by 91
Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism
Gammon, L., Biddle, A., Heywood, H. K., Johannessen, A. C., & Mackenzie, I. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062493 · Cited by 90
18F-HX4 hypoxia imaging with PET/CT in head and neck cancer
Chen, L., Zhang, Z., Kolb, H. C., Walsh, J. C., Zhang, J., & Guan, Y. (2012) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3283571016 · Cited by 90
Self-citationGene Expression Profile in Interleukin-4-Stimulated Human Vascular Endothelial Cells
Lee, Y. W., Eum, S. Y., Chen, K. C., Hennig, B., & Toborek, M. (2004) · Molecular Medicine · doi:10.2119/2004-00024.lee · Cited by 88
Newbold, K. L., Castellano, I. A., Charles-Edwards, E., Mears, D., Sohaib, A., Leach, M. O., Rhys‐Evans, P. H., Clarke, P. M., Fisher, C., Harrington, K. J., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.039 · Cited by 88
Ziemer, L. S., Lee, W. M. F., Vinogradov, S. A., Sehgal, C. M., & Wilson, D. F. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01140.2004 · Cited by 88
In vivo imaging and characterization of hypoxia-induced neovascularization and tumor invasion
Lungu, G. F., Li, M., Xie, X., Wang, L. V., & Stoica, G. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.1.45 · Cited by 87
Rudat, V., Vanselow, B., Wollensack, P., Bettscheider, C., Osman-Ahmet, S., Eble, M. J., & Dietz, A. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(00)00200-0 · Cited by 87
Bache, M., Kappler, M., Said, H. M., Staab, A., & Vordermark, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783497391 · Cited by 87
Carbonic Anhydrase IX in Early-Stage Non–Small Cell Lung Cancer
Kim, S. J., Rabbani, Z. N., Vollmer, R. T., Schreiber, E.-G., Oosterwijk, E., Dewhirst, M. W., Vujašković, Ž., & Kelley, M. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0636 · Cited by 87
Lyng, H., Sundfør, K., Tropé, C. G., & Rofstad, E. K. (2000) · PubMed · Cited by 87
Hypoxia in head and neck cancer
Isa, A., Ward, T. H., West, C., Slevin, N. J., & Homer, J. J. (2006) · British Journal of Radiology · doi:10.1259/bjr/17904358 · Cited by 86
The role of hypoxia inducible factor-1alpha in gynecological cancer
Seeber, L. M. S., Horrée, N., Vooijs, M., Heintz, A. P. M., van der Wall, E., Verheijen, R. H. M., & van Diest, P. J. (2010) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2010.05.003 · Cited by 86
Nordsmark, M., Eriksen, J. G., Gebski, V., Alsner, J., Horsman, M. R., & Overgaard, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.021 · Cited by 86
Elas, M., Bell, R., Hleihel, D., Barth, E. D., McFaul, C. A., Haney, C. R., Bielańska, J., Pustelny, K., Ahn, K., Pelizzari, C. A., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.022 · Cited by 85
Dence, C. S., Ponde, D. E., Welch, M. J., & Lewis, J. S. (2008) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.06.001 · Cited by 85
Canning, M. T., Postovit, L.-M. M., Clarke, S. H., & Graham, C. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5243 · Cited by 83
A New Method for Measuring Oxygen Concentration in Biological Systems
Vanderkooi, J. M., & Wilson, D. F. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5188-7_25 · Cited by 81
Mortensen, L. S., Buus, S., Nordsmark, M., Bentzen, L., Munk, O. L., Keiding, S., & Overgaard, J. (2010) · Acta Oncologica · doi:10.3109/0284186x.2010.516274 · Cited by 79
Cited by
ESPEN expert group recommendations for action against cancer-related malnutrition
Arends, J., Baracos, V., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E. P., Erickson, N., Laviano, A., Lisanti, M. P., Lobo, D. N., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.017 · Cited by 1,305
Tian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
HIFs, angiogenesis, and metabolism: Elusive enemies in breast cancer
de Heer, E. C., Jalving, M., & Harris, A. L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137552 · Cited by 372
Molecular imaging of the tumor microenvironment
Zhou, Z., & Lu, Z.-R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.012 · Cited by 253
Tumor hypoxia: From basic knowledge to therapeutic implications
Liao, C., Liu, X., Zhang, C., & Zhang, Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.011 · Cited by 223
Metadata
- Authors
- Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2014-10
- Volume
- 21
- Issue
- 10
- Pages
- 1516-1554
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2132719707
- Cited by
- 420
- References
- 274
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.